Chronic depletion of the c-Myc protein by AMPK activation would thus be expected to have a significant impact on cancer development: non-malignant cells can deal with declining ATP levels because AMPK regulates energy cellular pathways in response to metabolic alterations. Here, PRKAA1 is linked to cancer.